BlackRock’s Cubist Pharmaceuticals CBST Stock Holding History
Bought
Maintained
Sold
BlackRock's CBST Position: Q1 2015 in Review
BlackRock sold out of Cubist Pharmaceuticals (CBST) in Q1 2015, closing a stake of 582,621 shares — an estimated $58.6M sold.
BlackRock first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $58.6M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.
- BlackRock reported no remaining Cubist Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
- BlackRock sold 582,621 Cubist Pharmaceuticals shares in Q1 2015, an estimated $58.6M.
- BlackRock first reported a position in Cubist Pharmaceuticals in Q2 2013 and held it in 7 quarters.
- BlackRock's Cubist Pharmaceuticals position peaked at $58.6M in Q4 2014.
- 0 funds tracked by Wall St. Rank held Cubist Pharmaceuticals as of Q1 2015.
Based on BlackRock's 13F filing for Q1 2015, filed 13 May 2015.